JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Driscoll, B.
Right arrow Articles by Fung, Y. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Driscoll, B.
Right arrow Articles by Fung, Y. K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 14, 9463-9471, April 2, 1999

Discovery of a Regulatory Motif That Controls the Exposure of Specific Upstream Cyclin-dependent Kinase Sites That Determine Both Conformation and Growth Suppressing Activity of pRb

Barbara Driscoll, Anne T'Ang, Yi-Hui Hu, Chun Li Yan, Yue Fu, Yi Luo, Kai Jin Wu, Shumin Wen, Xiang-He Shi, Lora Barsky, Kenneth Weinberg, A. Linn Murphree, and Yuen Kai Fung

From the Divisions of Hematology/Oncology, Ophthalmology, Pathology, and Research Immunology/Bone Marrow Transplant, Childrens Hospital Los Angeles, and the Departments of Pediatrics, Microbiology, Ophthalmology, Pathology, and Immunology, University of Southern California, School of Medicine, Los Angeles, California 90027

The conformation and activity of pRb, the product of the retinoblastoma susceptibility gene, is dependent on the phosphorylation status of one or more of its 16 potential cyclin-dependent kinase (cdk) sites. However, it is not clear whether the phosphorylation status of one or more of these sites contributes to the determination of the various conformations and activity of pRb. Moreover, whether and how the conformation of pRb may regulate the phosphorylation of the cdk sites is also unclear. In the process of analyzing the function and regulation of pRb, we uncovered the existence of an unusual structural motif, m89 (amino acids 880-900), the mutation of which confers upon pRb a hypophosphorylated conformation. Mutation of this structural domain activates, rather than inactivates, the growth suppressor function of pRb. In order to understand the effect of the mutation of m89 on the phosphorylation of cdk sites, we identified all the cdk sites (Thr-356, Ser-807/Ser-811, and Thr821) the phosphorylation of which drastically modify the conformation of pRb. Mutation of each of these four sites alone or in combinations results in the different conformations of pRb, the migration pattern of which, on SDS-polyacrylamide gel electrophoresis, resembles various in vivo hypophosphorylated forms. Each of these hypophosphorylated forms of pRb has enhanced growth suppressing activity relative to the wild type. Our data revealed that the m89 structural motif controls the exposure of the cdk sites Ser-807/Ser-811 in vitro and in vivo. Moreover, the m89 mutant has enhanced growth suppressing activity, similar to a mutant with alanine substitutions at Ser-807/Ser-811. Our recent finding, that the m89 region is part of a structural domain, p5, conserved antigenically and functionally between pRb and p53, suggests that the evolutionarily conserved p5 domain may play a role in the coordinated regulation of the activity of these two tumor suppressors, under certain growth conditions.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
C. Evangelisti, P. L. Tazzari, M. Riccio, R. Fiume, Y. Hozumi, F. Fala, K. Goto, L. Manzoli, L. Cocco, and A. M. Martelli
Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts
FASEB J, October 1, 2007; 21(12): 3297 - 3307.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Enomoto, T. Mimura, D. L. Harris, and N. C. Joyce
Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4330 - 4340.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. M.R. Schmitz, A. Hirt, M. Aebi, and K. Leibundgut
Limited Redundancy in Phosphorylation of Retinoblastoma Tumor Suppressor Protein by Cyclin-Dependent Kinases in Acute Lymphoblastic Leukemia
Am. J. Pathol., September 1, 2006; 169(3): 1074 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K.-Y. Cheng, M. E. M. Noble, V. Skamnaki, N. R. Brown, E. D. Lowe, L. Kontogiannis, K. Shen, P. A. Cole, G. Siligardi, and L. N. Johnson
The Role of the Phospho-CDK2/Cyclin A Recruitment Site in Substrate Recognition
J. Biol. Chem., August 11, 2006; 281(32): 23167 - 23179.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Balasenthil and R. K. Vadlamudi
Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein
J. Biol. Chem., June 6, 2003; 278(24): 22119 - 22127.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
B. S. Dixon, D. Evanoff, W. B. Fang, and M. J. Dennis
Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1
Am J Physiol Cell Physiol, July 1, 2002; 283(1): C193 - C203.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. A. Dao, J. Hwa, and J. A. Nolta
Molecular mechanism of transforming growth factor beta -mediated cell-cycle modulation in primary human CD34+ progenitors
Blood, January 15, 2002; 99(2): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Wakino, U. Kintscher, S. Kim, S. Jackson, F. Yin, S. Nagpal, R. A. S. Chandraratna, W. A. Hsueh, and R. E. Law
Retinoids Inhibit Proliferation of Human Coronary Smooth Muscle Cells by Modulating Cell Cycle Regulators
Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 746 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
U. Kintscher, S. Wakino, S. Kim, S. M. Jackson, E. Fleck, W. A. Hsueh, and R. E. Law
Doxazosin Inhibits Retinoblastoma Protein Phosphorylation and G1->S Transition in Human Coronary Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1216 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Wakino, U. Kintscher, S. Kim, F. Yin, W. A. Hsueh, and R. E. Law
Peroxisome Proliferator-activated Receptor gamma Ligands Inhibit Retinoblastoma Phosphorylation and G1right-arrow S Transition in Vascular Smooth Muscle Cells
J. Biol. Chem., July 14, 2000; 275(29): 22435 - 22441.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.